Ryan Funk

Dr. Ryan Funk is an esteemed Associate Professor and Associate Chair in the Department of Pharmacy Practice at the University of Kansas. With a profound dedication to advancing the field of pharmacy, he has carved a niche in understanding the molecular mechanisms that contribute to variability in clinical responses to immunologically active agents, particularly in the context of pediatric autoimmune diseases. His research is pivotal in unraveling the complexities of how these agents interact with the human body, aiming to optimize therapeutic outcomes for young patients. In his role at the university, Dr. Funk is deeply committed to the academic and professional development of his students. He actively engages pharmacy and graduate students in both clinical and laboratory-based research, providing them with invaluable hands-on experience. His laboratory serves as a dynamic learning environment where students are encouraged to explore and contribute to cutting-edge research projects. Dr. Funk's mentorship is instrumental in shaping the next generation of pharmacists and researchers, equipping them with the skills and knowledge necessary to excel in their careers. Dr. Funk's teaching portfolio is as impressive as his research endeavors. He plays a crucial role in the pharmacotherapy and pharmacokinetics curriculum within the School of Pharmacy, where he imparts his expertise to students. Additionally, he offers elective coursework in drug development and precision medicine, areas that are increasingly important in the ever-evolving landscape of healthcare. His courses are designed to provide students with a comprehensive understanding of the intricacies involved in developing and optimizing drug therapies. A significant focus of Dr. Funk's research is on the factors that influence the response to disease-modifying anti-rheumatic drugs (DMARDs) in pediatric patients, with a particular emphasis on methotrexate. He is dedicated to identifying biomarkers that can guide the clinical use of these drugs, ultimately aiming to enhance their efficacy and safety. His work is crucial in ensuring that young patients receive the most effective treatments tailored to their individual needs. Dr. Funk's research extends to the disposition of biologic DMARDs in the pediatric population. He explores therapeutic approaches to improve exposure and response to these drugs, striving to overcome the challenges associated with their use in young patients. His contributions to this field are invaluable, as they hold the potential to significantly improve the quality of life for children suffering from autoimmune diseases. Through his research, teaching, and mentorship, Dr. Ryan Funk continues to make significant strides in the field of pharmacy, particularly in the realm of pediatric autoimmune disease treatment. His work not only advances scientific knowledge but also has a profound impact on the lives of patients and the future of pharmacy practice.